Memorial Sloan-Kettering Cancer Center

SK 520. Novel Retro-Alpha-Retinol Derivatives and Their Uses

Close Printer Formatted Version

Summary of Invention

This invention provides a purified retro-retinoid compound characterized by a molecular mass of about 302 daltons. This invention also provides methods for enhancing transcription of a gene regulated by retinoids in a cell as well as methods for treating disorders characterized by vitamin A deficiency.

Areas of Application

Therapeutic tool.

Lead Inventor

Dr. Jochen Buck

Patent Information

US patents:

Contact Information

Jeff Horenstein, PhD
Tel: 212-639-6181, Fax: 212-717-3439
E-mail: horenstj@mskcc.org

Return to Therapeutics Main Page
©2008 Memorial Sloan-Kettering Cancer Center.